Frontiers in Bioscience-Landmark,
Journal Year:
2024,
Volume and Issue:
29(11)
Published: Oct. 31, 2024
Systemic
lupus
erythematosus
(SLE)
is
a
multi-factorial
autoimmune-mediated
disease
with
hyper-stimulation
of
immune
cells
especially
the
T
lymphocytes.
By
this
method,
it
might
facilitate
systematic
damages
in
multiple
tissues
and
organs.
Otherwise,
SLE
also
correlated
diverse
cardio-metabolic
comorbidities,
including
dyslipidemia,
insulin
resistance,
hypertension.
It
worth-noting
that
risk
disorders
significantly
higher
compared
healthy
patients
which
was
reported
as
approximately
one-third
were
proved
obesity.
Notably,
current
focus
shifting
to
implementing
protective
strategies
well
elucidating
underlying
mechanisms
lupus-mediated
obese
status.
On
other
hand,
adipocyte,
most
abundant
endocrine
cell
fat
tissue,
are
dysfunctional
individuals
aberrant
secretion
adipokines.
proposing
adipokine
link
pathology
SLE,
whereas
related
mechanism
complicated.
In
review,
functions
potential
by
listed.
Furthermore,
recommendations,
identify
therapeutic
targets
for
treatment
summarized.
Journal of Neuroinflammation,
Journal Year:
2023,
Volume and Issue:
20(1)
Published: June 23, 2023
Neuroinflammation
is
a
vital
pathophysiological
process
during
ischemic
stroke.
Activated
astrocytes
play
major
role
in
inflammation.
Lipocalin-2
(LCN2),
secreted
by
activated
astrocytes,
promotes
neuroinflammation.
Pyroptosis
pro-inflammatory
form
of
programmed
cell
death
that
has
emerged
as
new
area
research
Nevertheless,
the
potential
LCN2
astrocyte
pyroptosis
remains
unclear.An
stroke
model
was
established
middle
cerebral
artery
occlusion
(MCAO)
vivo.
In
this
study,
vitro,
oxygen-glucose
deprivation
and
reoxygenation
(O/R)
were
applied
to
cultured
astrocytes.
24p3R
(the
receptor)
inhibited
astrocyte-specific
adeno-associated
virus
(AAV-GFAP-24p3Ri).
MCC950
Nigericin
sodium
salt
(Nig)
used
inhibit
or
promote
activation
NLRP3
inflammasome
pharmacologically,
respectively.
Histological
biochemical
analyses
performed
assess
neuron
death.
Additionally,
neurological
deficits
mice
evaluated.LCN2
expression
significantly
induced
24
h
after
onset
mouse
MCAO
model.
Lcn2
knockout
(Lcn2-/-)
exhibited
reduced
infarct
volume
improved
cognitive
functions
MCAO.
its
receptor
colocalized
Mechanistically,
suppression
AAV-GFAP-24p3Ri
alleviated
pyroptosis-related
pore
formation
secretion
cytokines
via
LCN2,
which
then
reversed
Nig-induced
activation.
Astrocyte
exacerbated
Lcn2-/-
intracerebroventricular
administration
recombinant
(rLCN2),
while
aggravation
restricted
blocking
inhibiting
with
MCC950.LCN2/24p3R
mediates
following
ischemia/reperfusion
injury.
Metabolism,
Journal Year:
2024,
Volume and Issue:
155, P. 155911 - 155911
Published: April 10, 2024
The
prevalence
of
metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
is
increasing
year
by
and
has
become
one
the
leading
causes
end-stage
worldwide.
Triggering
Receptor
Expressed
on
Myeloid
Cells
2
(Trem2)
been
confirmed
to
play
an
essential
role
in
progression
MASLD,
but
its
specific
mechanism
still
needs
be
clarified.
This
study
aims
explore
Trem2
MASLD.
Metabolism,
Journal Year:
2024,
Volume and Issue:
153, P. 155788 - 155788
Published: Jan. 18, 2024
Adipose
tissue
dysfunction
is
more
related
to
insulin
resistance
than
body
mass
index
itself
and
an
alteration
in
adipose
function
thought
underlie
the
shift
from
metabolically
healthy
unhealthy
obesity.
Herein,
we
performed
a
clustering
analysis
that
revealed
distinct
visceral
gene
expression
patterns
patients
with
obesity
at
stages
of
metabolic
dysregulation.
We
have
built
cross-sectional
cohort
aims
reflecting
evolution
sequelae
main
objective
map
sequential
events
play
role
(insulin-sensitive)
state
several
incremental
degrees
dysregulation,
encompassing
establishment,
pre-diabetes,
type
2
diabetes.
found
mainly
marked
by
downregulation
vasculature
remodeling-associated
expression,
suggesting
processes
like
angiogenesis
adaptative
expansion/retraction
ability
suffer
early
Prediabetes
was
characterized
compensatory
growth
factor-dependent
signaling
increased
response
hypoxia,
while
diabetes
associated
loss
cellular
hypoxia
concomitant
upregulation
inflammatory
markers.
Our
findings
suggest
putative
sequence
dysregulation
biological
not
linear
has
multiple
phases
across
process,
ultimately
culminating
climax
Several
studies
addressed
transcriptomic
changes
However,
best
our
knowledge,
this
first
study
unraveling
potential
molecular
mechanisms
multi-step
along
Journal of Advanced Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 1, 2025
Atherosclerosis
(AS),
a
major
cause
of
cardiovascular
diseases,
is
characterized
by
lipid
accumulation
and
chronic
inflammation
within
arterial
walls.
Traditional
treatments,
such
as
statins,
are
often
ineffective
for
many
patients,
highlighting
the
need
novel
therapeutic
strategies.
This
study
explores
potential
Resibufogenin
(RBG)
an
NLRP3
inflammasome
inhibitor
treating
AS
in
ApoE-/-
mice.
We
performed
experiments
encompassing
cellular
studies,
animal
model
assessments,
molecular
simulations,
binding
assays
to
assess
RBG's
impact
on
inflammasome,
inflammatory
cytokine
release,
foam
cell
formation.
RBG
treatment
alleviated
mice,
evidenced
reduced
body
weight,
smaller
atherosclerotic
plaques,
improved
serum
profiles.
Transcriptomics
biology
demonstrated
that
suppressed
expression
key
markers
NLRP3.
also
macrophage
infiltration
promoted
polarization
toward
anti-inflammatory
M2
phenotype.
Molecular
docking,
SPR,
Pull-down
studies
identified
non-covalent
interaction
between
CYS-279
residue
NLRP3,
confirming
its
role
potent
inhibitor.
effectively
inhibits
activation,
reduces
pro-inflammatory
decreases
formation
foamy
macrophages,
thereby
slowing
progression
AS.
Although
these
findings
highlight
promising
approach
further
research
necessary
safety
effectiveness
humans
investigate
possible
synergistic
effects
with
other
treatments.
Adipocyte,
Journal Year:
2025,
Volume and Issue:
14(1)
Published: April 29, 2025
CXCR7,
an
alternative
receptor
for
the
inflammatory
chemokine
SDF-1,
is
involved
in
cell
proliferation
and
migration.
Recent
studies
have
reported
that
CXCR7
also
plays
a
role
adipose
tissue.
However,
evidence
regarding
of
its
ligands
adipocyte
differentiation
limited.
In
this
study,
we
aimed
to
elucidate
changes
expression
during
SDF-1/CXCR7/CXCR4
axis
adipogenesis
using
recombinant
ligand
CCX771,
small
interfering
RNAs.
The
results
indicated
levels
SDF-1
receptors,
CXCR4,
decreased
early
stages
adipogenesis.
Treatment
with
CCX771
inhibited
lipid
accumulation
by
inducing
β-arrestin2,
Wnt
expression,
AKT
phosphorylation
downregulating
C/EBPα,
PPARγ,
FABP4
expression.
contrast,
knockdown
preadipocytes
downregulated
β-arrestin2/Wnt
pathway,
leading
induction
Meanwhile,
CXCR4
had
no
significant
effect.
mice,
basal
gene
were
higher
stromal
vascular
fraction
compared
mature
adipocytes
significantly
upregulated
high-fat
diet.
Our
provide
new
insights
into
local
SDF-1-CXCR7
offer
additional
benefits
prevention
obesity-related
metabolic
disorders.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Jan. 3, 2024
Abstract
Obstructive
sleep
apnea
syndrome
(OSAS)
and
obesity
go
hand
in
the
majority
of
patients
both
are
associated
with
a
systemic
inflammation,
immune
disturbance
comorbidities
such
as
cardiovascular
disease.
However,
unambiguous
impact
OSAS
on
individual
inflammatory
microenvironment
immunological
consequences
human
monocytes
has
not
been
distinguished
yet.
Therefore,
aim
this
study
was
to
investigate
related
factors
by
performing
flow
cytometric
whole
blood
measurements
CD14/CD16
monocyte
subsets
normal
weight
patients,
but
without
OSAS,
obesity,
compared
healthy
donors.
Moreover,
explicitly
plasma
levels
mediators
adiponectin,
leptin,
lipocalin
metalloproteinase-9
were
determined
influence
different
cytokine
secretion
expression
adhesion
molecules
THP-1
analysed.
Our
data
revealed
significant
redistribution
circulating
classical
intermediate
all
three
patient
cohorts,
differential
effects
terms
monocytic
CD11a,
CD11b,
CD11c,
CX3CR1,
CD29,
CD49d,
levels.
These
reflected
TNFα
hypoxia
patterns
CD11b
CD49d.
In
summary,
our
which
underlines
need
for
customized
therapeutic
regimen
respect
weighting
these
overlapping
diseases.
Cell Proliferation,
Journal Year:
2024,
Volume and Issue:
57(12)
Published: July 18, 2024
Aerobic
glycolysis
is
involved
in
the
pathogenesis
of
pulmonary
hypertension
(PH).
The
mechanisms
by
which
increased
and
how
it
contributes
to
vascular
remodelling
are
not
yet
fully
understood.
In
this
study,
we
demonstrated
that
elevated
lipocalin-2
(LCN2)
PH
significantly
enhances
aerobic
human
artery
smooth
muscle
cells
(PASMCs)
up-regulating
LDHA
expression.
Knockout
Lcn2
or
having
heterozygous
deficiency
mice
inhibits
progression
hypoxic
PH.
Our
study
reveals
LCN2
stimulates
expression
activating
Akt-HIF-1α
signalling
pathway.
Inhibition
Akt
HIF-1α
reduces
proliferation
PASMCs.
Both
play
critical
roles
development
suppressed
vessels
lacking
LCN2.
These
findings
shed
light
on
LCN2-Akt-HIF1α-LDHA
axis